Edgewood Oncology
Latest round
- Series A
Last raised
- Mar 2024
Total raised
- $10M
Investors
- 1
About Edgewood Oncology
Based in Massachusetts, US, Edgewood Oncology, Inc. operates as a biotechnology company that engages in the development of medication for individuals with solid tumors. Cook, and CMO, Zung Thai. The company engages in the development of treatments for patients with hematologic malignancies and genetically-defined solid tumors. Edgewood’s flagship product, BTX-A51, is a novel small-molecule multi-kinase inhibitor. BTX-A51 targets master regulators of cancer, including CK1a, CDK7, and CDK9, to activate programmed cell death, demonstrating promising clinical activity with a favorable safety profile. This mechanism of action holds promise in hematologic malignancies and genetically-defined solid tumors, such as GATA3-mutant breast cancer and Liposarcoma.
Who invested in Edgewood Oncology
1 investor across 1 round
See all investors in Edgewood Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 25, 2024
Amount
$10M
Investors
Questions about Edgewood Oncology
Who invested in Edgewood Oncology?
Edgewood Oncology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Edgewood Oncology raised?
Edgewood Oncology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Edgewood Oncology last raise money?
Edgewood Oncology's most recent round on record is a Series A, in Mar 2024.
What does Edgewood Oncology do?
Based in Massachusetts, US, Edgewood Oncology, Inc.
Where is Edgewood Oncology headquartered?
Edgewood Oncology is headquartered in Brookline, US.
Which VCs invest in companies like Edgewood Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Edgewood Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Edgewood Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.